Sahar M. Abou‐Seri
Sahar M. Abou‐Seri publishes mostly in Organic Chemistry, Molecular Biology and Pharmacology, on topics such as Synthesis and biological activity, Enzyme function and inhibition and Synthesis and Biological Evaluation.
- World rank
- #145,157 of 7,710,434 ranked researchers
- Rank in Egypt
- #387 of 36,277
- Works
- 80
- Citations
- 3.3k
- Citations per work
- 40.8
What does Sahar M. Abou‐Seri research?
Sahar M. Abou‐Seri's work is mostly in Chemistry (51%), Biochemistry, Genetics and Molecular Biology (24%), Medicine (11%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Physical Sciences4151.1%
- Chemistry4151.1%
- Life Sciences2328.3%
- Health Sciences910.7%
- Medicine910.7%
- Everything else89.9%
- 1Organic Chemistry48% of their works
- 2Molecular Biology24% of their works
- 3Pharmacology7% of their works
- 4Toxicology4% of their works
- 5Oncology4% of their works
- 6Physical and Theoretical Chemistry3% of their works
Research topics
- Synthesis and biological activity
- Enzyme function and inhibition
- Synthesis and Biological Evaluation
- Synthesis and Catalytic Reactions
- Cancer therapeutics and mechanisms
- Synthesis and Characterization of Heterocyclic Compounds
- Bioactive Compounds and Antitumor Agents
- Quinazolinone synthesis and applications
Which keywords describe Sahar M. Abou‐Seri's research?
The keywords of their largest research topics: Anticancer Agents, Medicinal Chemistry, Heterocyclic Compounds, Synthesis, Tubulin Inhibitors, Vascular Targeting Agents, Biological Evaluation and Drug Discovery.
- Quinazoline
- Toxicology
- Triazines
- Scaffold
- Quinoxaline
- Catalytic
- Carbonic Anhydrases
- Antimicrobial
- Antimicrobial Activity
- Drug Discovery
- Vascular Targeting Agents
- Synthesis
- Medicinal Chemistry
- Anticancer Agents
- Heterocyclic Compounds
- Tubulin Inhibitors
- Biological Evaluation
- Inhibitors
- Anticancer
- Activators
- Amination
- Derivatives
- DNA
- Topoisomerases
- Quinones
- Indirubin
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 26 words, with their numbers
- Anticancer Agents784 topics
- Medicinal Chemistry633 topics
- Heterocyclic Compounds512 topics
- Synthesis444 topics
- Tubulin Inhibitors391 topic
- Vascular Targeting Agents391 topic
- Biological Evaluation323 topics
- Drug Discovery282 topics
- Inhibitors282 topics
- Antimicrobial Activity222 topics
- Anticancer202 topics
- Antimicrobial202 topics
- Activators171 topic
- Carbonic Anhydrases171 topic
- Amination121 topic
- Catalytic121 topic
- Derivatives121 topic
- Quinoxaline121 topic
- DNA111 topic
- Scaffold111 topic
- Topoisomerases111 topic
- Triazines111 topic
- Quinones101 topic
- Toxicology101 topic
- Indirubin91 topic
- Quinazoline91 topic
Where does Sahar M. Abou‐Seri work?
Sahar M. Abou‐Seri's main affiliation in the publication record is Cairo University, Egypt.
How many publications and citations does Sahar M. Abou‐Seri have?
OpenAlex counts 80 works and 3,262 citations for Sahar M. Abou‐Seri, an h-index of 33, ranking #145,157 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Sahar M. Abou‐Seri. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.